AI Verdict
MBOT has stronger fundamentals based on our AI analysis.
MBX vs MBOT Fundamental Comparison
| Metric | MBX | MBOT |
|---|---|---|
| Revenue | N/A | $2,000.0 |
| Net Income | $-87.0M | $-13.1M |
| Net Margin | N/A | -657,100.0% |
| ROE | -23.6% | -16.9% |
| ROA | -22.6% | -16.1% |
| Current Ratio | 24.62x | 23.33x |
| Debt/Equity | 0.00x | 0.03x |
| EPS | $-2.38 | $-0.29 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MBX vs MBOT: Frequently Asked Questions
Is MBX or MBOT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MBOT has stronger fundamentals. MBX is rated STRONG SELL (92% confidence) while MBOT is rated STRONG SELL (95% confidence). This is not investment advice.
How does MBX compare to MBOT fundamentally?
MBX Biosciences, Inc. has ROE of -23.6% vs Microbot Medical Inc.'s -16.9%. Net margins are N/A vs -657,100.0% respectively.
Which stock pays higher dividends, MBX or MBOT?
MBX has a dividend yield of N/A or no dividend while MBOT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MBX or MBOT for long term?
For long-term investing, consider that MBX has STRONG SELL rating with 92% confidence, while MBOT has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MBX vs MBOT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MBX vs MBOT, the AI consensus favors MBOT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.